Because histone deacetylase 1 (HDAC1) inhibition lowers pathological cardiac hypertrophy [56] and oxidative stress [57], we assessed the exosomal level of maspin, an HDAC1 inhibitor delivered by exosomes [58, 59]. This evidence concerns the gene SERPINB5 and cardiac hypertrophy.